Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBSORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBSENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBSENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBSNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.2.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.2.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.2.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAHORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAHENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAHENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAHNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBJ.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBJ.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBJ.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBJ.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EP.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EP.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EP.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EP.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CL.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CL.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CL.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CL.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBF.8.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBF.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.8.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAUORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAUENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAUENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAUNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAY.1.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAY.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.1.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.25.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.25.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used